Protalix BioTherapeutics (PLX) Gains from Investment Securities (2010 - 2026)
Protalix BioTherapeutics' quarterly Gains from Investment Securities came in at $2.5 million in Q1 2026, up 7475.76% year-on-year from $33000.0 in Q1 2025, and up 181.22% quarter-over-quarter from -$3.1 million in Q4 2025.
Protalix BioTherapeutics has reported Gains from Investment Securities for 17 years, with the latest figure at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 7475.76% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at -$565000.0 (down 276.67% YoY), and the FY2025 full-year result was $2.1 million, down 71.73% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $2.5 million, up from -$3.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.5 million in Q1 2026, with the low at -$3.1 million in Q4 2025.
- Average Gains from Investment Securities over 5 years is $53999.4, with a median of $99000.0 recorded in 2022.
- Year-over-year, Gains from Investment Securities tumbled 725.2% in 2025 and surged 7475.76% in 2026.
- Tracing PLX's Gains from Investment Securities over 5 years: stood at $427000.0 in 2022, then sank by 428.81% to -$1.4 million in 2023, then jumped by 73.43% to -$373000.0 in 2024, then plunged by 725.2% to -$3.1 million in 2025, then jumped by 181.22% to $2.5 million in 2026.
- The last three Gains from Investment Securities figures came in at $2.5 million (Q1 2026), -$3.1 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | -3.08 Mn |
| Dec 31, 2025 | -3.08 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | -373,000.00 |
| Dec 31, 2024 | -373,000.00 |
| Sep 30, 2024 | 360,000.00 |
| Sep 30, 2024 | 360,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | -1.40 Mn |
| Dec 31, 2023 | -1.40 Mn |
| Sep 30, 2023 | 316,000.00 |
| Sep 30, 2023 | 316,000.00 |
| Jun 30, 2023 | 767,000.00 |
| Jun 30, 2023 | 767,000.00 |
| Mar 31, 2023 | 312,000.00 |
| Mar 31, 2023 | 312,000.00 |
| Dec 31, 2022 | 427,000.00 |
| Dec 31, 2022 | 427,000.00 |
| Sep 30, 2022 | -526,000.00 |
| Sep 30, 2022 | -526,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 58,000.00 |
| Dec 31, 2021 | 58,000.00 |
| Jun 30, 2021 | -71,000.00 |
| Jun 30, 2021 | -71,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 972,000.00 |
| Dec 31, 2020 | 972,000.00 |
| Sep 30, 2020 | -409,000.00 |
| Sep 30, 2020 | -409,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Dec 31, 2019 | 329,000.00 |
| Dec 31, 2019 | 329,000.00 |
| Sep 30, 2019 | 80,000.00 |
| Sep 30, 2019 | 80,000.00 |
| Jun 30, 2019 | 160,000.00 |
| Jun 30, 2019 | 160,000.00 |
| Mar 31, 2019 | -13,000.00 |
| Mar 31, 2019 | -13,000.00 |
| Dec 31, 2018 | 37,000.00 |
| Dec 31, 2018 | 37,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Mar 31, 2018 | -109,000.00 |
| Mar 31, 2018 | -109,000.00 |
| Dec 31, 2017 | -74,000.00 |
| Dec 31, 2017 | -74,000.00 |
| Sep 30, 2017 | -15,000.00 |
| Sep 30, 2017 | -15,000.00 |
| Jun 30, 2017 | 43,000.00 |
| Jun 30, 2017 | 43,000.00 |
| Mar 31, 2017 | 40,000.00 |
| Mar 31, 2017 | 40,000.00 |
| Dec 31, 2016 | 14,000.00 |
| Dec 31, 2016 | 14,000.00 |
| Sep 30, 2016 | -91,000.00 |
| Sep 30, 2016 | -91,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Mar 31, 2016 | 42,000.00 |
| Mar 31, 2016 | 42,000.00 |
| Dec 31, 2015 | -54,000.00 |
| Dec 31, 2015 | -54,000.00 |
| Sep 30, 2015 | 41,000.00 |
| Sep 30, 2015 | 41,000.00 |
| Mar 31, 2014 | 50,000.00 |
| Mar 31, 2014 | 50,000.00 |
| Dec 31, 2013 | 49,000.00 |
| Dec 31, 2013 | 49,000.00 |
| Sep 30, 2013 | 50,000.00 |
| Sep 30, 2013 | 50,000.00 |
| Jun 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 24,000.00 |
| Mar 31, 2013 | 47,000.00 |
| Mar 31, 2013 | 47,000.00 |
| Dec 31, 2012 | 45,000.00 |
| Dec 31, 2012 | 45,000.00 |
| Sep 30, 2012 | 49,000.00 |
| Sep 30, 2012 | 49,000.00 |
| Jun 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 2,000.00 |
| Mar 31, 2012 | 42,000.00 |
| Mar 31, 2012 | 42,000.00 |
| Dec 31, 2011 | 43,000.00 |
| Dec 31, 2011 | 43,000.00 |
| Sep 30, 2011 | 45,000.00 |
| Sep 30, 2011 | 45,000.00 |
| Jun 30, 2011 | 31,000.00 |
| Jun 30, 2011 | 31,000.00 |
| Mar 31, 2011 | 46,000.00 |
| Mar 31, 2011 | 46,000.00 |
| Dec 31, 2010 | 148,000.00 |
| Dec 31, 2010 | 148,000.00 |
| Sep 30, 2010 | -71,000.00 |
| Sep 30, 2010 | -71,000.00 |